FDA may authorize half-dose booster of Moderna’s coronavirus vaccine
By
Alicia Lasek
Sep 30, 2021
A 50-microgram dose appears to be effective enough to increase waning vaccine protection, and may reduce the risk of side effects, sources tell investigators.
Vaccination nation
By
Jean Wendland Porter
Aug 11, 2021
Last week an insurance adjuster came over to scope out some storm damage. Anyone who enters my home must be vaccinated or wear a mask (I keep clean masks at the front door. I’m nice like that). If...
BREAKING: LeadingAge joins call for COVID-19 vaccine mandate for all healthcare workers
By
James M. Berklan
Jul 26, 2021
LeadingAge joined a list of at least 56 other professional healthcare groups that came out Monday morning in favor of a COVID-19 vaccine mandate for all healthcare workers.
NIH head says full Pfizer vaccine approval could come this summer
By
Kimberly Marselas
Jul 20, 2021
Waiting for full federal approval of Pfizer’s COVID-19 vaccine is no reason to delay protection, the director of the National Institutes of Health said Monday, but those still holding out for the end...
CDC says COVID-19 vaccine boosters not yet necessary, while Pfizer seeks approval for third dose
By
Alicia Lasek
Jul 12, 2021
Fully vaccinated Americans do not need a COVID-19 booster shot at this time, according to federal health officials. But Pfizer has asked to offer a third dose of its current vaccine and is developing an...
Clinical briefs for Monday, June 7
By
Alicia Lasek
Jun 07, 2021
NIC: Nursing homes among ‘safest places’ for seniors following 98% drop in COVID cases … Vaccination is not a risk factor for sudden hearing loss: Johns Hopkins … U.S. population estimate foresees...
Providers see slight increase in COVID vaccine uptake among staff
By
Danielle Brown
May 04, 2021
Long-term care staffers are increasingly opening up to the COVID-19 vaccines, according to the latest insights from the National Investment Center for Seniors Housing & Care (NIC).
Older adults who have received J&J need not be concerned: expert
By
Amy Novotney
Apr 20, 2021
Joshua Sharfstein, M.D., vice dean for public health practice and community engagement at Johns Hopkins University, has a message for older adults who have received the Johnson & Johnson COVID-19 vaccine:...
Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
Clinical briefs for Wednesday, March 3
By
Alicia Lasek
Mar 03, 2021
Senior living chief medical officer reflects on COVID a year into pandemic, including vaccine acceptance … NIH halts convalescent plasma trial in ED patients with mild COVID symptoms … Stroke patients...